SLCO2A1 and colorectal carcinoma: A previous study suggested that reduced OATP2A1 expression in colorectal carcinoma might enhance colorectal cancer20; however, there is no direct in vivo or in vitro evidence for OATP2A1 contributing to processes affecting colorectal tumour progression.